Posts Tagged: Biotechnology


Nanotechnologies are proving to have a major impact on oil spill cleanup innovation in recent years. Researchers at Ohio State University have pioneered a type of mesh coated with a fluorosurfactant, a material which attracts water but repels oil. …

Continue Reading

The USPTO continues to issue patents related to biotechnology and organic chemistry inventions despite the Supreme Court rulings and USPTO guidelines implementing the ruling related to the scope of patentable subject matter. Although the sky has not fallen, applicants …

Continue Reading

There have been reports of technological advances which could make bionic vision a reality. One company, Occumetrics Technology Corp. of British Columbia, Canada, has been making a stir with claims of a bionic lens which could help recipients to …

Continue Reading

This statute tried to mirror the Hatch-Waxman statute for small molecules, including both an abbreviated drug approval process and a mechanism to address any patent claims during drug approval. However, because of the differences between these two types of …

Continue Reading

Global innovation continued to climb during 2014 but at the slowest pace seen since the global economic recession hit in 2009. The Reuters report didn’t draw any specific conclusions as to why the innovation slowdown had occurred but did draw …

Continue Reading

Although the consequences posed by climate change could be dire, there’s no reason to believe that human ingenuity and innovation cannot provide a path forward to answer these challenges... Methods of developing fuel from biological sources on the …

Continue Reading

For the past 90 years WARF has promoted scientific research and innovation at UW-Madison and has earned more than $800 million in patent royalty revenues over the years and has generated $1.25 billion in revenue for the institution. WARF’s success spans …

Continue Reading

Cystic fibrosis creates a thick, sticky mucus that builds up in the airways, causing infections, and making it difficult to breathe. Chronic pain is a common problem for patients, which increases dramatically during the last 6 months of life. Those …

Continue Reading

In a least one instance, a major laboratory test provider has indicated (in confidence) that it would not be entering the Ebola testing market for three principle reasons: (1) the lack of availability of exclusivity for genetic testing; (2) the liability …

Continue Reading

A look into the recently published patent applications assigned to Dow from the U.S. Patent and Trademark Organization shows us that GMOs and herbicides have been a major area of focus for Dow and Dow AgroSciences, its chief …

Continue Reading

We saw in our coverage of Eli Lilly’s patent applications a number of recently developed medications for the management of conditions like diabetes and inflammatory diseases, but the company is also focused on developing solutions to medical problems …

Continue Reading

On the very same day that the U.S. jobs report shows unexpectedly weak growth, the Federal Court of Australia issued a ruling directly opposite to the ruling rendered by the United States Supreme Court relative to gene patents. …

Continue Reading